Personalized Pathology & Cancer Therapy
21 – 30 of 48
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters (
- Prognostic role of the tumour microenvironment in esophago-gastric, pancreatic and periampullary adenocarcinoma: B cells and beyond (
- The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size (
- Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer (
- The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype (
- High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort (
- Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups (
- Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer (
- 2016
- The prognostic impact of NK/NKT cell density in periampullary adenocarcinoma differs by morphological type and adjuvant treatment (
- Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer (